AK112 Combined With Chemotherapy as the First-line Treatment in Advanced Esophageal Squamous Cell Carcinoma Patients

NCT06489197 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

ESCC
Advanced Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Ivonescimab combined with albumin paclitaxel and cisplatin

Sponsor

Tianjin Medical University Cancer Institute and Hospital